49 results
Page 2 of 3
8-K
EX-99.1
97ss1hf4dkxnd41a
6 Jun 23
Departure of Directors or Certain Officers
4:08pm
8-K
EX-99.1
2ntiy4
15 May 23
Absci Reports Business Updates and First Quarter 2023 Financial and Operating Results
4:08pm
ARS
mf381
28 Apr 23
Annual report to shareholders
12:00am
PRE 14A
obbqhd5 q0
11 Apr 23
Preliminary proxy
5:49pm
8-K
EX-99.1
kx3p6cc
30 Mar 23
Absci Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
4:10pm
8-K
EX-99.1
um40f8a46qckknn
9 Nov 22
Absci Reports Third Quarter 2022 Financial Results
9:18am
8-K
EX-99.1
umb3xixy9 xdxu72d1v0
2 Nov 22
Absci Welcomes Meta Senior Executive to Board of Directors
4:06pm
8-K
swzevipez8z22wc98
4 Oct 22
Absci Appoints Veteran Pharma Executive Andreas Busch, PhD as Chief Innovation Officer
4:09pm
8-K
EX-99.1
w95k30sv
4 Oct 22
Absci Appoints Veteran Pharma Executive Andreas Busch, PhD as Chief Innovation Officer
4:09pm
DEF 14A
pelomq 5dwwmkxmmtqt8
26 Apr 22
Definitive proxy
4:39pm
10-K
qufr psopct
22 Mar 22
Annual report
5:20pm
8-K
EX-99.1
pi0tlhys8szmlk4
22 Mar 22
Absci Reports Full Year 2021 Financial and Operating Results
4:07pm
8-K
EX-99.1
frxid yculwu4ue2q1h3
9 Nov 21
Absci Reports Third Quarter 2021 Financial and Operating Results
8:02am
10-Q
0i6a5b7
7 Sep 21
Quarterly report
8:48am